Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lithium Americas Corp (LAC) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Lithium Americas CorpTrade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

Lithium Americas Corp vs Roivant Sciences Ltd. Common Shares — how do they compare? Lithium Americas Corp trades at $2.35 (market cap $850.38M), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 29.1× Lithium Americas Corp's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lithium Americas Corp for 27 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.

LACROIV
Market Cap
$850.38M$24.72B
Volume
8,804,6376,279,442
Sector
Basic MaterialsHealth
52-Week High
$10.05$41.81
52-Week Low
$2.35$16.04
Typical Hold Time
27 Days1 Days
Enterprise Value
$1.19B$20.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lithium Americas Corp

Lithium Americas (LAC) trades at $2.36, down 2.07% with a bearish technical signal despite bullish oscillators. The company shows negative profitability with ROE at -9.56% and ROA at -3.99%, though it has beaten EPS estimates in recent quarters. Analyst consensus is mixed with 47% buy ratings and a $4.00 price target, representing 69% upside potential. Recent news highlights construction progress at Thacker Pass and a $175 million financing round to strengthen the balance sheet.

LAC presents a high-risk, high-reward opportunity as it transitions from development to execution phase. The stock trades below book value (P/B 0.6) but faces significant execution risks and negative cash flow from operations. Upside depends on successful lithium production ramp-up and favorable lithium pricing, while downside risks include project delays and commodity price volatility.

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LAC
25% Buy75% Sell
Avg holding period · 27 Days
ROIV

No sentiment data available yet.

Top news

Latest headlines on both assets

About Lithium Americas Corp

Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.

Read more on LAC →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →